A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells

Journal of Gene Medicine

Volumn 9, Issue 5, 2007, Pages 335-344

  Fischer, Yvonne Heidemarie ^a   Miletic, Hrvoje ^b   Giroglu, Tsanan ^c   Litwak, Sara ^d   Stenzel, Werner ^b   Neumann, Harald ^d   von Laer, Dorothee ^c  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Institute of Reconstructive Neurobiology ^*  (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GREEN FLUORESCENT PROTEIN; POL PROTEIN; RETROVIRUS VECTOR; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENE THERAPY; CANCER INFILTRATION; CELL INFILTRATION; CELL ISOLATION; CELL MIGRATION; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; FREEZE THAWING; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOBLASTOMA; GLIOMA CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PSEUDOTYPING; RAT; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; BONE MARROW CELLS; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; GENE THERAPY; GENETIC VECTORS; GLIOMA; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MOLONEY MURINE LEUKEMIA VIRUS; RATS; RETROVIRIDAE; TRANSDUCTION, GENETIC; VIRAL PROTEINS; VIRUS ASSEMBLY;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; RATTUS;

EID: 34249034432     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1032     Document Type: Article

References (27)

1. Kleihues P, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-225; discussion 226-229.
2. Oertel J, et al. Prognosis of gliomas in the 1970s and today. Neurosurg Focus 2005; 18: e12.
3. Culver KW, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
4. Ram Z, et al. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 1993; 79: 400-407.
5. Rainov NG, et al. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ ganciclovir paradigm. Cancer Gene Ther 1996; 3: 99-106.
6. Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 2000; 11: 2389-2401.
7. Sandmair AM, et al. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 2000; 11: 2197-2205.
8. Rainov NG, Ren H. Clinical trials with retrovirus mediated gene therapy - what have we learned? J Neurooncol, 2003; 65: 227-236.
9. Aboody KS, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 2000; 97: 12846-12851.
10. Ehtesham M, et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62: 5657-5663.
11. Lee J, et al. Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antighorna cellular vector. Cancer Res 2003; 63: 8877-8889.
12. Nakamura K, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155-1164.
13. Moore XL, et al. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 2004; 11: 811-818.
14. Tabatabai G, et al. Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain 2005; 128: 2200-2211.
15. Jiang Y, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
16. Beyer WR, et al. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol 2002; 76: 1488-1495.
17. Miletic H, et al. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum Gene Ther 2004; 15: 1091-1100.
18. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063-1066.
19. Demaison C, et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803-813.
20. Schambach A, et al. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther 2000; 2: 435-445.
21. Zufferey R, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
22. Bruns M, et al. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 1983; 130: 247-251.
23. Palu G, et al. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. Gene Ther 1999; 6: 330-337.
24. Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
25. Steffens S, et al. Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes. J Neurooncol 2004; 70: 281-288.
26. Yang Y, et al. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 1995; 6: 1203-1213.
27. Ram Z, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997; 3: 1354-1361.